Drug profile · INN
rosiglitazone
AVANDAMET
rosiglitazone (AVANDAMET) is a peroxisome proliferator-activated receptor gamma agonist.
EMA: unknown Alimentary tract and metabolism (A10) A10BD03
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — rosiglitazone
- Class
- Alimentary tract and metabolism (A10)
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.83
Quick answer
rosiglitazone (AVANDAMET) is a peroxisome proliferator-activated receptor gamma agonist.
Key facts
INN rosiglitazone
Brand AVANDAMET
Mechanism Peroxisome proliferator-activated receptor gamma agonist
Target Peroxisome proliferator-activated receptor gamma
Therapeutic class Alimentary tract and metabolism (A10)
ATC code A10BD03
Mechanism of action
Peroxisome proliferator-activated receptor gamma agonist
Primary target: Peroxisome proliferator-activated receptor gamma
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | unknown | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is rosiglitazone?
rosiglitazone (AVANDAMET) is a peroxisome proliferator-activated receptor gamma agonist.
What is the brand name for rosiglitazone?
AVANDAMET is a marketed brand name for rosiglitazone. Check FDA Drugs@FDA for the current US label holder and prescribing information.